|
AKAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.406200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.885600E-01 |
| Normal-vs-Stage2 |
6.050800E-01 |
| Normal-vs-Stage3 |
8.594700E-04 |
| Normal-vs-Stage4 |
9.982000E-03 |
| Stage1-vs-Stage2 |
6.096200E-01 |
| Stage1-vs-Stage3 |
1.375350E-03 |
| Stage1-vs-Stage4 |
1.132120E-02 |
| Stage2-vs-Stage3 |
1.658240E-01 |
| Stage2-vs-Stage4 |
2.382000E-01 |
| Stage3-vs-Stage4 |
8.577400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.476770E-01 |
| Normal-vs-AfricanAmerican |
3.007900E-02 |
| Normal-vs-Asian |
9.482800E-01 |
| Caucasian-vs-AfricanAmerican |
1.102250E-01 |
| Caucasian-vs-Asian |
6.823000E-01 |
| AfricanAmerican-vs-Asian |
3.722400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.706480E-02 |
| Normal-vs-Female |
6.481000E-01 |
| Male-vs-Female |
1.228640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.190800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.493200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.796390E-02 |
| Normal-vs-Age(81-100Yrs) |
4.692100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.355200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.984000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.775400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.098170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.469630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.307200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.417430E-01 |
| Normal-vs-Grade 2 |
8.787000E-01 |
| Normal-vs-Grade 3 |
6.363300E-04 |
| Normal-vs-Grade 4 |
1.448480E-02 |
| Grade 1-vs-Grade 2 |
4.053800E-02 |
| Grade 1-vs-Grade 3 |
3.407700E-02 |
| Grade 1-vs-Grade 4 |
3.862700E-03 |
| Grade 2-vs-Grade 3 |
1.800520E-03 |
| Grade 2-vs-Grade 4 |
2.523800E-02 |
| Grade 3-vs-Grade 4 |
8.768200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.853400E-01 |
| Normal-vs-ccB subtype |
3.570200E-02 |
| ccA subtype-vs-ccB subtype |
3.916100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.154200E-02 |
| Normal-vs-N1 |
5.997400E-01 |
| N0-vs-N1 |
9.811400E-01 |
|
|
